The Government has today published its plans for the UK’s future immigration system.
The NHS has today published its Long Term Plan setting out what it will be prioritising in the future.
The ABPI has named Elliot Dunster as its Executive Director of Communications.
The Association of the British Pharmaceutical Industry (ABPI) – the trade group representing the branded pharmaceutical industry in the UK – has responded to the outcome of the meaningful vote on the Withdrawal Agreement and Political Deceleration.
The UK Government has launched their National Action Plan to tackle antimicrobial resistance. It sets out how Britain will achieve its new 20-year vision for a world in which AMR is contained and controlled by 2040, covering health, animals, the environment and the food chain.
The UK must plug an increasing number of science skills gaps to maintain its world-leading position for medicines and vaccines research and development, says the ABPI.
Dr Sheuli Porkess of the ABPI applauds the Sector Deal 2 for helping to boost opportunities for patients to engage in research, but says there’s more to do.
Patients could have access to new, ground-breaking medicines up to six months earlier and the NHS across the UK is expected to save around £930 million on its medicine bill under a new scheme being finalised between the pharmaceutical industry and the Government.
The ABPI and BIA have submitted a joint submission in response to the MHRA and DHSC consultation on 'no deal' contingency legislation for medicines and devices regulation for the UK.
Professor Carole Longson, Chief Scientific Officer at the Association of the British Pharmaceutical Industry gives her nominations for a woman in science to go on the £50 note.
The value of Scotland’s pharmaceutical industry is revealed today in a new report by the Fraser of Allander Institute which shows the significant contribution the sector makes to all parts of the Scottish economy.